Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 5401 AL 5415

Profile of gantenerumab and its potential in the treatment of Alzheimer's disease

Novakovic D, Feligioni M, Scaccianoce S, Caruso A, Piccinin S, Schepisi C, Errico F, Mercuri NB, Nicoletti F, Nisticò R.

Drug Des Devel Ther. 2013 Nov 13;7:1359-64. doi: 10.2147/DDDT.S53401. eCollection 2013.

Dance with me

Aka S.

Can Nurse. 2013 Oct;109(8):30-1.

Regenerative medicine in Alzheimer's disease

Felsenstein KM, Candelario KM, Steindler DA, Borchelt DR.

Transl Res. 2014 Apr;163(4):432-8. doi: 10.1016/j.trsl.2013.11.001. Epub 2013 Nov 8.

[Present and future of the tau dementia therapy]

Takashima A.

Rinsho Shinkeigaku. 2013;53(11):1040-2. doi: 10.5692/clinicalneurol.53.1040.

[Molecular targeting and translational research for new therapeutic strategies on Alzheimer's disease]

Takata K.

Yakugaku Zasshi. 2013;133(12):1389-99. doi: 10.1248/yakushi.13-00219.

[Does gender really affect the socio-economic characteristics of the primary caregiver in Alzheimer's disease?]

Ruiz-Adame Reina M, González-Camacho MC, Mainar Causapé A.

Gac Sanit. 2014 May-Jun;28(3):258. doi: 10.1016/j.gaceta.2013.09.004. Epub 2013 Dec 2.

Potential novel targets for Alzheimer pharmacotherapy: II. Update on secretase inhibitors and related approaches

Mikulca JA, Nguyen V, Gajdosik DA, Teklu SG, Giunta EA, Lessa EA, Tran CH, Terak EC, Raffa RB.

J Clin Pharm Ther. 2014 Feb;39(1):25-37. doi: 10.1111/jcpt.12112. Epub 2013 Dec 8.

[The Balance of Care approach for the development of custom-fit health care services for people with dementia on the margins of care between home and nursing home: experiences with its application in Germany]

Stephan A, Renom Guiteras A, Juchems S, Meyer G.

Z Evid Fortbild Qual Gesundhwes. 2013;107(9-10):597-605. doi: 10.1016/j.zefq.2013.10.018. Epub 2013 Nov 11.

Calcium channelopathies and Alzheimer's disease: insight into therapeutic success and failures

Chakroborty S, Stutzmann GE.

Eur J Pharmacol. 2014 Sep 15;739:83-95. doi: 10.1016/j.ejphar.2013.11.012. Epub 2013 Dec 6.

A small molecule that displays marked reactivity toward copper- versus zinc-amyloid-β implicated in Alzheimer's disease

Savelieff MG, Liu Y, Senthamarai RR, Korshavn KJ, Lee HJ, Ramamoorthy A, Lim MH.

Chem Commun (Camb). 2014 May 25;50(40):5301-3. doi: 10.1039/c3cc48473d. Epub 2013 Dec 10.

Novel tacrine analogs as potential cholinesterase inhibitors in Alzheimer's disease

El-Malah A, Gedawy EM, Kassab AE, Salam RM.

Arch Pharm (Weinheim). 2014 Feb;347(2):96-103. doi: 10.1002/ardp.201300121. Epub 2013 Dec 16.

Disease-modifying drugs in Alzheimer's disease

Ghezzi L, Scarpini E, Galimberti D.

Drug Des Devel Ther. 2013 Dec 6;7:1471-8. doi: 10.2147/DDDT.S41431.

Electronic organiser and Alzheimer's disease: fact or fiction?

Imbeault H, Bier N, Pigot H, Gagnon L, Marcotte N, Fulop T, Giroux S.

Neuropsychol Rehabil. 2014;24(1):71-100. doi: 10.1080/09602011.2013.858641. Epub 2013 Dec 23.

Tau-aggregation inhibitor therapy for Alzheimer's disease

Wischik CM, Harrington CR, Storey JM.

Biochem Pharmacol. 2014 Apr 15;88(4):529-39. doi: 10.1016/j.bcp.2013.12.008. Epub 2013 Dec 19.

A caregiver's wish list for a National Alzheimer's Agenda

Vann AS.

Am J Alzheimers Dis Other Demen. 2014 Mar;29(2):111-3. doi: 10.1177/1533317513511292. Epub 2013 Dec 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias